Next Article in Journal
A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland
Next Article in Special Issue
Photodynamic Synergistic Effect of Pheophorbide a and Doxorubicin in Combined Treatment against Tumoral Cells
Previous Article in Journal
Care at the Very End-of-Life: Dying Cancer Patients and Their Chosen Family’s Needs
Previous Article in Special Issue
A Comparison of Singlet Oxygen Explicit Dosimetry (SOED) and Singlet Oxygen Luminescence Dosimetry (SOLD) for Photofrin-Mediated Photodynamic Therapy
Review

Interstitial Photodynamic Therapy—A Focused Review

1
Photodynamic Therapy Center, Department of Cell Stress Biology, Roswell Park Cancer Institute (RPCI), Elm & Carlton Streets, Buffalo, NY 14263, USA
2
Simphotek, Inc., 211 Warren St, Newark, NJ 07103, USA
*
Author to whom correspondence should be addressed.
Academic Editor: Michael R. Hamblin
Cancers 2017, 9(2), 12; https://doi.org/10.3390/cancers9020012
Received: 1 December 2016 / Revised: 13 January 2017 / Accepted: 20 January 2017 / Published: 24 January 2017
(This article belongs to the Special Issue Photodynamic Cancer Therapy)
Multiple clinical studies have shown that interstitial photodynamic therapy (I-PDT) is a promising modality in the treatment of locally-advanced cancerous tumors. However, the utilization of I-PDT has been limited to several centers. The objective of this focused review is to highlight the different approaches employed to administer I-PDT with photosensitizers that are either approved or in clinical studies for the treatment of prostate cancer, pancreatic cancer, head and neck cancer, and brain cancer. Our review suggests that I-PDT is a promising treatment in patients with large-volume or thick tumors. Image-based treatment planning and real-time dosimetry are required to optimize and further advance the utilization of I-PDT. In addition, pre- and post-imaging using computed tomography (CT) with contrast may be utilized to assess the response. View Full-Text
Keywords: interstitial photodynamic therapy; prostate; head and neck; pancreatic; brain; treatment planning interstitial photodynamic therapy; prostate; head and neck; pancreatic; brain; treatment planning
Show Figures

Figure 1

MDPI and ACS Style

Shafirstein, G.; Bellnier, D.; Oakley, E.; Hamilton, S.; Potasek, M.; Beeson, K.; Parilov, E. Interstitial Photodynamic Therapy—A Focused Review. Cancers 2017, 9, 12. https://doi.org/10.3390/cancers9020012

AMA Style

Shafirstein G, Bellnier D, Oakley E, Hamilton S, Potasek M, Beeson K, Parilov E. Interstitial Photodynamic Therapy—A Focused Review. Cancers. 2017; 9(2):12. https://doi.org/10.3390/cancers9020012

Chicago/Turabian Style

Shafirstein, Gal; Bellnier, David; Oakley, Emily; Hamilton, Sasheen; Potasek, Mary; Beeson, Karl; Parilov, Evgueni. 2017. "Interstitial Photodynamic Therapy—A Focused Review" Cancers 9, no. 2: 12. https://doi.org/10.3390/cancers9020012

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop